Depreciation, Depletion and Amortization of Strata Critical Medical, Inc. from 30 Sep 2019 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary: Strata Critical Medical, Inc. annual and quarterly Depreciation, Depletion and Amortization in USD history and change rate from 30 Sep 2019 to 31 Dec 2025.
Strata Critical Medical, Inc. Depreciation, Depletion and Amortization for the quarter ending 30 Jun 2025 was $1,776,000, a 14% increase year-over-year.
Strata Critical Medical, Inc. Depreciation, Depletion and Amortization for the twelve months ending 30 Jun 2025 was $6,282,000, a 7.6% decline year-over-year.
Strata Critical Medical, Inc. annual Depreciation, Depletion and Amortization for 2025 was $8,185,000, a 37% increase from 2024.
Strata Critical Medical, Inc. annual Depreciation, Depletion and Amortization for 2024 was $5,962,000, a 16% decline from 2023.
Strata Critical Medical, Inc. annual Depreciation, Depletion and Amortization for 2023 was $7,111,000, a 24% increase from 2022.
Source SEC data: View on sec.gov

Depreciation, Depletion and Amortization, Annual (USD)

Depreciation, Depletion and Amortization, YoY Annual Change (%)

Depreciation, Depletion and Amortization, Trailing 12 Months (USD)

Depreciation, Depletion and Amortization, Quarterly (USD)

Depreciation, Depletion and Amortization, YoY Quarterly Change (%)

Strata Critical Medical, Inc. Annual Depreciation, Depletion and Amortization (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2025	$8,185,000	+$2,223,000	+37%	01 Jan 2025	31 Dec 2025	10-K	03 Mar 2026	2025	FY
2024	$5,962,000	-$1,149,000	-16%	01 Jan 2024	31 Dec 2024	10-K	03 Mar 2026	2025	FY
2023	$7,111,000	+$1,386,000	+24%	01 Jan 2023	31 Dec 2023	10-K	13 Mar 2025	2024	FY
2022	$5,725,000	+$5,129,000	+861%	01 Jan 2022	31 Dec 2022	10-K	12 Mar 2024	2023	FY
2021	$596,000	+$70,000	+13%	01 Oct 2020	30 Sep 2021	10-K	16 Mar 2023	2022	FY
2020	$526,000	+$54,000	+11%	01 Oct 2019	30 Sep 2020	10-K	20 Dec 2021	2021	FY
2019	$472,000			01 Oct 2018	30 Sep 2019	10-K	20 Dec 2021	2021	FY

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2025	$6,282,000	$1,776,000	+$217,000	+14%	01 Apr 2025	30 Jun 2025	10-Q	05 Aug 2025	2025	Q2
Q1 2025	$6,065,000	$1,697,000	+$103,000	+6.5%	01 Jan 2025	31 Mar 2025	10-Q	12 May 2025	2025	Q1
Q4 2024	$5,962,000	$1,530,000	-$276,000	-15%	01 Oct 2024	31 Dec 2024	10-K	03 Mar 2026	2025	FY
Q3 2024	$6,238,000	$1,279,000	-$564,000	-31%	01 Jul 2024	30 Sep 2024	10-Q	12 Nov 2024	2024	Q3
Q2 2024	$6,802,000	$1,559,000	-$251,000	-14%	01 Apr 2024	30 Jun 2024	10-Q	05 Aug 2025	2025	Q2
Q1 2024	$7,053,000	$1,594,000	-$58,000	-3.5%	01 Jan 2024	31 Mar 2024	10-Q	12 May 2025	2025	Q1
Q4 2023	$7,111,000	$1,806,000			01 Oct 2023	31 Dec 2023	10-K	13 Mar 2025	2024	FY
Q3 2023		$1,843,000			01 Jul 2023	30 Sep 2023	10-Q	12 Nov 2024	2024	Q3
Q2 2023		$1,810,000			01 Apr 2023	30 Jun 2023	10-Q	08 Aug 2024	2024	Q2
Q1 2023		$1,652,000	+$507,000	+44%	01 Jan 2023	31 Mar 2023	10-Q	07 May 2024	2024	Q1
Q1 2022		$1,145,000	+$1,019,000	+809%	01 Jan 2022	31 Mar 2022	10-Q	11 May 2023	2023	Q1
Q4 2021		$717,000	+$578,000	+416%	01 Oct 2021	31 Dec 2021	10-K	16 Mar 2023	2022	FY
Q1 2021		$126,000			01 Jan 2021	31 Mar 2021	10-Q	10 May 2022	2022	Q1
Q4 2020		$139,000			01 Oct 2020	31 Dec 2020	8-K	10 Jan 2023

* An asterisk sign (*) next to the value indicates that the value is likely invalid.